10x Genomics, Inc. · NASDAQ:TXG
Saxonov Serge sold 28,893 10x Genomics, Inc. shares (Form 4)
Traded May 22 to May 26, 2026 · Filed May 27, 2026
From May 22 to May 26, 2026, Saxonov Serge (Director, Chief Executive Officer) sold 28,893 10x Genomics, Inc. shares at an average US$24.54 for US$709K under a trading plan, leaving 1,138,380 shares. Filed May 27, 2026 (Form 4).
- Sold
- 28,893 shares
- Price
- US$24.54 average (US$24.44 to US$24.71)
- Value
- US$709K
- Holding after
- 1,138,380 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 22, 2026 | Class A Common Stock | Sale | 18,175 | US$24.44 | 1,149,098 | Direct |
| May 26, 2026 | Class A Common Stock | Sale | 10,718 | US$24.71 | 1,138,380 | Direct |
Source
Related
- 10x Genomics, Inc.
- Saxonov Serge
- 10x Genomics, Inc. shareholders
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Saxonov Serge · Sep 3, 2026
- Form 4 · Saxonov Serge · Aug 28, 2026
- Form 4 · Saxonov Serge · Aug 26, 2026
- Form 4 · Saxonov Serge · Aug 24, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Form 4 · Stuelpnagel John R · Sep 8, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Sep 8, 2026